<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">Attempts have been made to boost brain uptake of drugs across the BBB.
 <xref rid="bib9" ref-type="bibr">9</xref>, 
 <xref rid="bib10" ref-type="bibr">10</xref>, 
 <xref rid="bib11" ref-type="bibr">11</xref>, 
 <xref rid="bib12" ref-type="bibr">12</xref> Various receptors (e.g., insulin
 <xref rid="bib13" ref-type="bibr">13</xref>, 
 <xref rid="bib14" ref-type="bibr">14</xref> and transferrin
 <xref rid="bib15" ref-type="bibr">
  <sup>15</sup>
 </xref>) have been targeted, where, by way of transcytosis, drugs were expected to be delivered to exert effects on the brain. Positive results have been reported in mice, rats, and monkeys, and recently in some patients with MPS I.
 <xref rid="bib14" ref-type="bibr">
  <sup>14</sup>
 </xref> Different administration routes (e.g., intrathecal
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref> and intracerebroventricular
 <xref rid="bib17" ref-type="bibr">
  <sup>17</sup>
 </xref> injections) have been attempted with the aim of directly delivering the enzymes to the brain, but practical difficulties for both patients and physicians remain significant hurdles to overcome.
</p>
